导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.74% | 645/1050 |
| 近一周 | -1.86% | 795/1104 |
| 近一月 | -1.90% | 128/1103 |
| 近一季 | -0.09% | 292/1094 |
| 近半年 | -0.09% | 489/1074 |
| 近一年 | 4.12% | 473/1020 |
| 近两年 | 31.85% | 665/926 |
| 近三年 | 22.48% | 473/834 |
| 成立以来 | 63.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.81% 853/1070 |
5.09% 618/1101 |
- - |
- - |
| 2025 | 14.81% 758/1065 |
-0.59% 835/1014 |
0.11% 672/1038 |
8.32% 877/1050 |
6.51% 92/1065 |
| 2024 | 17.70% 121/1011 |
4.35% 119/960 |
4.68% 107/983 |
11.00% 547/991 |
-2.92% 529/1011 |
| 2023 | -13.73% 467/952 |
2.62% 471/880 |
-4.76% 506/895 |
-5.65% 354/915 |
-6.45% 631/952 |
| 2022 | -18.23% 264/867 |
-16.96% 356/773 |
9.13% 295/806 |
-10.66% 284/845 |
1.00% 383/867 |
| 2021 | -8.09% 463/740 |
-5.53% 362/580 |
8.39% 402/659 |
-12.73% 570/704 |
2.86% 311/740 |
| 2020 | 56.80% 208/554 |
5.59% 68/419 |
24.88% 195/466 |
8.10% 299/517 |
10.01% 358/554 |
| 2019 | 42.23% 203/410 |
18.74% 944/1149 |
-0.10% 353/1231 |
12.10% 77/390 |
6.96% 278/410 |
| 2018 | -27.58% 186/349 |
- - |
- - |
- - |
-13.80% 813/1080 |
| 2017 | -3.64% 184/285 |
- - |
- - |
- - |
- - |
| 2016 | -21.56% 122/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 南方产业活力 VS. 东吴新产业精选股票A(580008) |